Idiopathic pulmonary fibrosis and interleukins: a bibliometric analysis [1999–2025]
Jiayi Xu, Sixian Chen, Linxin Liu, Jinming Zhang, Yi Min, Huifen Zhou · 2026
Read Idiopathic pulmonary fibrosis and interleukins: a bibliometric analysis [1999–2025] by Jiayi Xu, Sixian Chen, Linxin Liu, Jinming Zhang, Yi Min, Huifen Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13460226.txt.
Description
Jiayi Xu and co-authors map in 2026 research linking idiopathic pulmonary fibrosis with interleukins, a family of immune signaling proteins. Interest in this pairing has grown because some interleukin pathways drive scarring while others might be druggable. Searching two databases, the team gathered 832 papers and fifteen clinical studies, then charted themes, cited links, and keyword bursts with mapping software spanning 1999 to 2025.
Attention to the field is rising steadily, led by the United States and China. Mechanism studies and treatment strategy work dominate the themes, and bursting keywords include the antifibrotic drug pirfenidone alongside diagnosis and fibrosis itself. The authors present interleukins as promising markers and offer their map to guide lab checks and patient grouping for future trials.
Catalog record
| CREATOR | Jiayi Xu, Sixian Chen, Linxin Liu, Jinming Zhang, Yi Min, Huifen Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |